Jason was diagnosed with mantle cell lymphoma in 2019, a rare and aggressive type of B-cell non-Hodgkin lymphoma. He shares his path to treatment, his experience participating in a clinical trial and learning the best way to be your own advocate despite challenges in the healthcare system.
Jason was diagnosed with mantle cell lymphoma in 2019, a rare and aggressive type of B-cell non-Hodgkin lymphoma. He shares his path to treatment, his experience participating in a clinical trial and learning the best way to be your own advocate despite challenges in the healthcare system.
CLEAR ALL